Vaccine development to combat infectious disease transmission doesn't stop at successfully producing a product, but also encompasses the ability to conduct clinical trials, ensure production and regulatory readiness, and ensure the vaccine's acceptance and use by the public. Therefore, UGM is encouraging efforts to develop research capacity, build cross-border collaborative networks, and encourage vaccine research and innovation […]
The article …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Vaccine development to combat infectious disease transmission doesn't stop at successfully producing a product, but also encompasses the ability to conduct clinical trials, ensure production and regulatory readiness, and ensure the vaccine's acceptance and use by the public. Therefore, UGM is encouraging efforts to develop research capacity, build cross-border collaborative networks, and encourage vaccine research and innovation […]
The article …